Karl K Ng

Title: Innovations of Karl K Ng in Cancer Treatment

Introduction

Karl K Ng is a notable inventor based in Warwick, RI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds useful in the treatment of cancer. With a total of 2 patents, his work is recognized for its potential impact on medical science.

Latest Patents

Ng's latest patents focus on the enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and their salts. These compounds are designed to treat hyperproliferative diseases, including various forms of cancer in mammals. The patents also detail processes for producing enantiomerically pure or optically enriched forms of these compounds using continuous chromatography.

Career Highlights

Karl K Ng is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on innovative solutions for complex health issues, particularly in oncology.

Collaborations

Ng has collaborated with notable colleagues, including R Mark Guinn and Subramanian Sam Guhan. These partnerships have contributed to the advancement of his research and the development of new therapeutic options.

Conclusion

Karl K Ng's contributions to cancer treatment through his innovative patents highlight the importance of research and collaboration in the pharmaceutical industry. His work continues to pave the way for advancements in medical science.